Vimal D. Mehta

Director, Chief Executive Officer, President & Secretary at BioXcel Therapeutics, Inc.

Vimal D. Mehta

Vimal D. Mehta

Director, Chief Executive Officer, President & Secretary at BioXcel Therapeutics, Inc.

Overview
Career Highlights

BioXcel Therapeutics, Inc.
BioXcel LLC
BioXcel Corp.

RelSci Relationships

105

Number of Boards

2

Birthday

1961

Age

60

Relationships
RelSci Relationships are individuals Vimal D. Mehta likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at BioXcel Corp.

Relationship likelihood: Strong

Managing Member at Bearing Circle Advisors LLC

Relationship likelihood: Strong

Executive Chairman at Rgenix, Inc.

Relationship likelihood: Strong

Director-BioTech Council at US India Chamber of Commerce

Relationship likelihood: Strong

Chief Financial Officer & Vice President at BioXcel Therapeutics, Inc.

Relationship likelihood: Strong

Chief Scientific Officer, Bioxcel Therapeutics, Inc at BioXcel Corp.

Relationship likelihood: Strong

Executive Vice President & Chief Commercial Officer at BioXcel Therapeutics, Inc.

Relationship likelihood: Strong

Chief Development Officer & Senior Vice President at BioXcel Therapeutics, Inc.

Relationship likelihood: Strong

Chief Medical Officer at BioXcel Therapeutics, Inc.

Relationship likelihood: Strong

European Principal Investigator at BioXcel Therapeutics, Inc.

Relationship likelihood: Strong

Paths to Vimal D. Mehta
Potential Connections via
Relationship Science
You
Vimal D. Mehta
Director, Chief Executive Officer, President & Secretary at BioXcel Therapeutics, Inc.
Education

University of Delhi is a premier Indian educational institution, with a status so high that president of India serves as the Visitor.

Career History
Director, Chief Executive Officer, President & Secretary
2017 - Current

BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company, which focuses on drug development. The firm's two clinical development programs are BXCL501, a sublingual thin film formulation designed for acute treatment of agitation resulting from neurological and psychiatric disorders, and BXCL701, an immuno-oncology agent designed for treatment of a rare form of prostate cancer and for treatment of pancreatic cancer. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT.

Co-Founder
2005 - Current

BioXcel Corp. is an American private company located in Branford, CT. The firm provides pharma data analytics solutions. It was founded by Krishnan Nandabalan and Vimal D. Mehta. Vimal D. Mehta is the current CEO, occupying that position since 2005. BioXcel Corp. owns a significant share in BioXcel Therapeutics, Inc. (41.08 %).The company says this about itself: BioXcel is a biopharmaceutical company pioneering the integration of big data analytics and machine learning-based artificial intelligence with drug development expertise to advance the next wave of medicines, impacting the probability of success of drugs. Our focus is to develop innovative medicines that address immuno-oncology, neuroscience and rare diseases with high unmet medical need. Committed to innovation, product excellence and partner success, BioXcel's global collaborations span the biopharmaceutical ecosystem. We are headquartered in Branford, CT, USA with operations in Asia.

Chief Executive Officer
Current
Transactions
Details Hidden

BioXcel Therapeutics, Inc. issued USD Common Stock

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Vimal D. Mehta. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Vimal D. Mehta's profile does not indicate a business or promotional relationship of any kind between RelSci and Vimal D. Mehta.